skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialodecaosylceramide > alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer

اصطلاح مرجح

alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-[alpha-d-galnac-(1->3)-[alpha-l-fuc-(1->2)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->6)]-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C98H165N6O60R

جرم

  • 2387.36290

جرم تک‌ایزوتوپی

  • 2386.00445

اسمایلٓ

  • [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]2[C@H](O)[C@@H](NC(C)=O)[C@@H](O[C@@H]2CO)O[C@H]2[C@@H](O)[C@@H](CO[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5NC(C)=O)[C@H]4O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H](O)[C@H]3NC(C)=O)O[C@@H](O[C@H]3[C@H](O)[C@@H](NC(C)=O)[C@@H](O[C@@H]3CO)O[C@H]3[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@H](OC[C@H](NC([*])=O)[C@H](O)/C=C/CCCCCCCCCCCCC)O[C@@H]4CO)[C@@H]3O)[C@@H]2O)[C@@H]1O)C(O)=O)[C@H](O)[C@H](O)CO

زیرمجموعه

  • 3_STAR

مترادف دقیق

  • (2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)-[alpha-L-fucopyranosyl-(1->2)]-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

مترادف مرتبط

  • alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-Cer
  • alpha-Neu5Ac-(2->3)-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-[alpha-GalNAc-(1->3)-[alpha-Fuc-(1->2)]-beta-Gal-(1->4)-beta-GlcNAc-(1->6)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer
  • alpha-Neu5Ac-(2->3)-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-[alpha-GalNAc-(1->3)-[alpha-Fuc-(1->2)]-beta-Gal-(1->4)-beta-GlcNAc-(1->6)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-Cer
  • alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-[alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->6)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
  • alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-[alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->6)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-Cer
  • (Gal)4 (GalNAc)1 (Glc)1 (GlcNAc)3 (LFuc)1 (Neu5Ac)1 (Cer)1
  • Human glycolipid G9-A

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:62564

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD